(NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that their partner, Norgine Pharmaceuticals Ltd., has launched PEDMARQSI ...

When European pharma company Norgine saw an unmet need in how patients were seeking information on one of its brands, they decided to implement a chatbot to help people find the answers they needed.

RESEARCH TRIANGLE PARK, N.C. - Fennec Pharmaceuticals (NASDAQ:FENC) Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that ...

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, announced that Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, has commercially launched Pedmarqsi ...

Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the ...

If you’re not yet using a collagen supplement, let this be your sign to start. If you already know about collagen’s function in the body – it’s the single most prolific protein that provides tissues ...